Business Description
Actelion Ltd
NAICS : 325411
SIC : 2833
ISIN : CH0119210984
Compare
Compare
Traded in other countries / regions
ATLNE.Switzerland Description
Actelion is a Swiss biopharmaceutical firm with several products on the market, largely focused on pulmonary arterial hypertension: Tracleer, Opsumit, Uptravi, Ventavis, and Veletri treat various stages of the disease via different methods of administration. Zavesca is a second-line option for Gaucher disease, and Valchlor treats a rare form of blood cancer. Actelion has created a global commercial infrastructure for its approved orphan drugs and has supplemented its internal pipeline through in-licensing and acquisitions.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.69 | |||||
| Interest Coverage | 6852.04 | |||||
| Piotroski F-Score | 8/9 | |||||
| Altman Z-Score | 28.36 | |||||
| Beneish M-Score | -2.88 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 13.2 | |||||
| 3-Year EBITDA Growth Rate | 19.2 | |||||
| 3-Year EPS without NRI Growth Rate | 18.1 | |||||
| 3-Year FCF Growth Rate | 17.8 | |||||
| 3-Year Book Growth Rate | -5.8 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 13.37 |
Momentum Rank
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.76 | |||||
| Quick Ratio | 2.51 | |||||
| Days Inventory | 169.01 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Dividend Growth Rate | 14.5 | |||||
| 3-Year Average Share Buyback Ratio | 2.5 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 89.38 | |||||
| Operating Margin % | 32.12 | |||||
| Net Margin % | 28.89 | |||||
| FCF Margin % | 35.94 | |||||
| ROE % | 50.89 | |||||
| ROA % | 34.22 | |||||
| ROIC % | 79.6 | |||||
| ROC (Joel Greenblatt) % | 156.43 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 41.95 | |||||
| PE Ratio without NRI | 41.95 | |||||
| Price-to-Owner-Earnings | 36.07 | |||||
| PEG Ratio | 0.72 | |||||
| PS Ratio | 12.13 | |||||
| PB Ratio | 17.84 | |||||
| Price-to-Tangible-Book | 26 | |||||
| Price-to-Free-Cash-Flow | 33.77 | |||||
| Price-to-Operating-Cash-Flow | 31.64 | |||||
| EV-to-EBIT | 8.91 | |||||
| EV-to-EBITDA | 8.02 | |||||
| EV-to-Revenue | 2.86 | |||||
| Price-to-Projected-FCF | 4.1 | |||||
| Price-to-Median-PS-Value | 2.23 | |||||
| Price-to-Net-Current-Asset-Value | 39.79 | |||||
| Price-to-Net-Cash | 815.75 | |||||
| Earnings Yield (Greenblatt) % | 11.21 | |||||
| FCF Yield % | 3.03 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Actelion Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil CHF) | 2,474.656 | ||
| EPS (TTM) (CHF) | 0 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR (CHF) | 0 | ||
| 20-Day SMA (CHF) | 0 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (CHF) | 60.5 - 115.5 | ||
| Shares Outstanding (Mil) | 126.77 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Actelion Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Actelion Ltd Stock Events
| Event | Date | Price(CHF) | ||
|---|---|---|---|---|
| No Event Data | ||||
Actelion Ltd Frequently Asked Questions
What is Actelion Ltd(XSWX:ATLNE)'s stock price today?
The current price of XSWX:ATLNE is CHF65.26. The 52 week high of XSWX:ATLNE is CHF115.50 and 52 week low is CHF60.50.
When is next earnings date of Actelion Ltd(XSWX:ATLNE)?
The next earnings date of Actelion Ltd(XSWX:ATLNE) is .
Does Actelion Ltd(XSWX:ATLNE) pay dividends? If so, how much?
Actelion Ltd(XSWX:ATLNE) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers